Global Interventional Cardiology Market 2017-2021

  • ID: 4039638
  • Report
  • Region: Global
  • 123 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 6

FEATURED COMPANIES

  • Aachen Resonance
  • AtriCure
  • Cardionovum
  • Gadelius Medical
  • Medtronic
  • SHOCKWAVE Medical
  • MORE
About Interventional Cardiology

Interventional cardiology devices are primarily related to heart disease, and most of the heart diseases have some serious medical conditions, such as angina, congestive heart failure, and arrhythmias. These are often caused by partially blocked coronary arteries, which is the most common cause of death globally.

Since the 1980s, balloon angioplasty has been the standard method for treating coronary artery disease. Coronary artery disease (CAD) blocks the artery that supplies blood to the heart. It occurs when the coronary artery is narrowed or blocked with the formation of plaque, which forms due to reasons such as cholesterol, fatty deposits, calcium, and other substances.

The analysts forecast the global interventional cardiology market to grow at a CAGR of 7.15% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global interventional cardiology market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of interventional cardiovascular devices to key end-users such as hospitals and ambulatory surgical centers (ASCs).

The market is divided into the following segments based on geography:

- Americas
- APAC
- EMEA

The report, Global Interventional Cardiology Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Abbott Vascular
- Boston Scientific
- Cordis
- Medtronic
- St. Jude Medical

Other prominent vendors
- Aachen Resonance
- Acrostak
- Alvimedica
- AngioScore
- Arthesys
- Asahi Intecc
- AtriCure
- B. Braun
- Biosensors International
- Biotronik
- BrosMed Medical
- C.R. Bard
- Cardionovum
- Coherex Medical
- Cook Medical
- Cardiovascular Systems
- Elixir Medical
- Fortimedix
- Gadelius Medical
- GaltNeedleTech
- Gore Medical
- Hexacath
- JOTEC
- Lepu Medical Technology
- Medinol
- Meril Life Sciences
- Merit Medical Systems
- MicroPort Scientific
- Natec Medical
- OptiMed
- Reva Medical
- SHOCKWAVE Medical
- Simeks Medical
- Smiths Medical
- Spectranetics
- STENTYS
- Svelte medical
- Teleflex
- Terumo
- Tokai Medical Products
- US Endovascular
- Volcano

Market drivers
- Increasing incidences of cardiac disorders and rise in older population
- For a full, detailed list, view the full report

Market challenges
- High cost of interventional cardiology procedures
- For a full, detailed list, view the full report

Market trends
- Emergence of bioabsorbable stents
- For a full, detailed list, view the full report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Aachen Resonance
  • AtriCure
  • Cardionovum
  • Gadelius Medical
  • Medtronic
  • SHOCKWAVE Medical
  • MORE
Part 01: Executive summary

Part 02: Scope of the report
  • Top-vendor offerings
Part 03: Market research methodology
  • Research methodology
  • Economic indicators
Part 04: Introduction
  • Key market highlights
  • Market snapshot
Part 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
Part 06: Market segmentation by product type
  • Coronary stents
  • PTCA balloon catheters
  • Interventional guide wires
  • Interventional cardiology imaging systems
  • LAA closure devices
  • Atherectomy devices
Part 07: Global coronary stents market
  • Market overview
  • Market size and forecast
Part 08: Global interventional cardiology PTCA balloon catheter market
  • Market overview
  • Market size and forecast
Part 09: Global interventional cardiology guide wires market
  • Market overview
  • Market size and forecast
Part 10: Global interventional cardiology imaging systems markets
  • Market overview
  • Market size and forecast
Part 11: Global LAA closure devices market
  • Market overview
  • Market size and forecast
Part 12: Global atherectomy devices
  • Market overview
  • Market size and forecast
Part 13: Market segmentation by end-user
  • ASCs
  • Hospitals
  • Physicians' offices
Part 14: Geographical segmentation
  • Interventional cardiology market in Americas
  • Interventional cardiology market in EMEA
  • Interventional cardiology market in APAC
Part 15: Market drivers
  • Increasing incidences of cardiac disorders and rise in older population
  • Advances in technology
  • Growing demand for MI procedures
  • Favorable reimbursement policies
Part 16: Impact of drivers

Part 17: Market challenges
  • High cost of interventional cardiology procedures
  • Complications associated with usage of interventional cardiology devices
  • Stringent regulation for approval of devices
  • Pricing pressure coupled with lack of product differentiation
Part 18: Impact of drivers and challenges

Part 19: Market trends
  • Emergence of bioabsorbable stents
  • Increase in M&A
  • Growing popularity of hybrid procedures
  • Focus on emerging countries
Part 20: Vendor landscape
  • Competitive scenario
Part 21: Key vendor analysis
  • Abbott Vascular
  • Boston Scientific
  • Cordis4
  • Medtronic8
  • St. Jude Medical
  • Other prominent vendors
Part 22: Appendix
  • List of abbreviations
Part 23: About the Author

List of Exhibits

Exhibit 01: Product offerings
Exhibit 02: Causes of vascular diseases
Exhibit 03: Overview of stents used in cardiovascular interventions
Exhibit 04: Features of guide wires
Exhibit 05: Comparison of materials used in PTCA catheters
Exhibit 06: Global interventional cardiology market 2016-2021 ($ billions)
Exhibit 07: Global interventional cardiology market: Market analysis
Exhibit 08: Global interventional cardiology market: Metrics analysis 2016 and 2021
Exhibit 09: Five forces analysis
Exhibit 10: Global interventional cardiology market segmentation by product type
Exhibit 11: Global interventional cardiology market segmentation by product type 2016
Exhibit 12: Global interventional cardiology market segmentation by product type 2021
Exhibit 13: Global coronary stents market 2016-2021 ($ billions)
Exhibit 14: Global coronary stents market segmentation by category
Exhibit 15: Segmentation of global coronary stents market by stent type 2016 (%)
Exhibit 16: Global interventional cardiology PTCA balloon catheters market 2016-2021 ($ billions)
Exhibit 17: Global interventional cardiology PTCA balloon catheters market segmentation by category
Exhibit 18: Segmentation of global interventional cardiology PTCA balloon catheters market by product type 2016 (%)
Exhibit 19: Global interventional cardiology guide wires market 2016-2021 ($ billions)
Exhibit 20: Global interventional cardiology imaging systems segmentation by product
Exhibit 21: Global interventional cardiology imaging systems market 2016-2021 in ($ billions)
Exhibit 22: Global interventional cardiology imaging systems segmentation by product type 2016 (%)
Exhibit 23: Global LAA closure devices market 2016-2021 ($ millions)
Exhibit 24: Global LAA closure devices segmentation by product
Exhibit 25: Global atherectomy devices market 2016-2021 ($ millions)
Exhibit 26: Global interventional cardiology market analysis 2016
Exhibit 27: Global interventional cardiology market segmentation by product type 2016-2021 ($ billions)
Exhibit 28: Global interventional cardiology market segmentation by product type 2016-2021 (%)
Exhibit 29: Global interventional cardiology market segmentation by end-user 2016
Exhibit 30: Comparison of reimbursement for ASCs, hospital outpatient dePartments, and physicians' offices in the US
Exhibit 31: Segmentation of global interventional cardiology market by geography 2016-2021 (%)
Exhibit 32: Interventional cardiology market in Americas 2016-2021 in ($ billions)
Exhibit 33: Interventional cardiology market in EMEA 2016-2021 in ($ billions)
Exhibit 34: Interventional cardiology market in APAC 2016-2021 in ($ billions)
Exhibit 35: Segmentation of global interventional cardiology market by geography 2016-2021 ($ billions)
Exhibit 36: Segmentation of global interventional cardiology market by geography 2016-2021 (%)
Exhibit 37: Estimated percentage of aging population (aged above 50) in 2012 and 2050
Exhibit 38: Impact of drivers
Exhibit 39: Impact of drivers and challenges
Exhibit 40: List of few bioabsorbable coronary stents approved or in approval stage in the US and Europe
Exhibit 41: Some of the notable M&As
Exhibit 42: Global interventional cardiology market: Strategic success factors of companies
Exhibit 43: Competitive structure analysis of global interventional cardiology market 2015
Exhibit 44: Market penetration of various manufacturers of interventional cardiology market 2016
Exhibit 45: Abbott Vascular : Profile
Exhibit 46: Abbott Vascular: Strength analysis
Exhibit 47: Abbott Vascular: Growth strategy matrix
Exhibit 48: Abbott Vascular: Opportunity assessment
Exhibit 49: Boston Scientific: Profile
Exhibit 50: Boston Scientific: Strength analysis
Exhibit 51: Boston Scientific: Growth strategy matrix
Exhibit 52: Boston Scientific: Opportunity assessment
Exhibit 53: Cordis: Profile
Exhibit 54: Cordis: Strength analysis
Exhibit 55: Cordis growth: Strategy matrix
Exhibit 56: Cordis: Opportunity assessment
Exhibit 57: Medtronic: Profile
Exhibit 58: Medtronic: Strength analysis
Exhibit 59: Medtronic: Growth strategy matrix
Exhibit 60: Medtronic: Opportunity assessment
Exhibit 61: St. Jude Medical: Profile
Exhibit 62: St. Jude Medical: Strength analysis
Exhibit 63: St. Jude Medical: Growth strategy matrix
Exhibit 64: St. Jude Medical: Opportunity assessment
Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • Aachen Resonance
  • AtriCure
  • Cardionovum
  • Gadelius Medical
  • Medtronic
  • SHOCKWAVE Medical
  • MORE
New Report Released: - Global Interventional Cardiology Market 2017-2021

The author of the report recognizes the following companies as the key players in the global interventional cardiology market: Abbott Vascular, Boston Scientific, Cordis, Medtronic, and St. Jude Medical

Other Prominent Vendors in the market are: Aachen Resonance, Acrostak, Alvimedica, AngioScore, Arthesys, Asahi Intecc, AtriCure, B. Braun, Biosensors International, Biotronik, BrosMed Medical, C.R. Bard, Cardionovum, Coherex Medical, Cook Medical, Cardiovascular Systems, Elixir Medical, Fortimedix, Gadelius Medical, GaltNeedleTech, Gore Medical, Hexacath, JOTEC, Lepu Medical Technology, Medinol, Meril Life Sciences, Merit Medical Systems, MicroPort Scientific, Natec Medical, OptiMed, Reva Medical, SHOCKWAVE Medical, Simeks Medical, Smiths Medical, Spectranetics, STENTYS, Svelte medical, Teleflex, Terumo, Tokai Medical Products, US Endovascular, and Volcano

Commenting on the report, an analyst from the research team said: “The introduction of new stents, such as biodegradable scaffolds, bioabsorbable polymers, and bifurcation stents, is projected to increase the utilization of stents in CADs. These stents have the potential to eliminate the negative issues of long-lasting polymer stents, which will prompt a significant shift in the treatment of conditions such as atherosclerosis, stenosis or fibrous disease. The conception of bioabsorbable stents has created interest since the past 20 years and the latest advances with the stent dissolving from the treated site with improved lesion have resulted in better enhancement in the treatment with the help of imaging, such as magnetic resonance and computed tomography. Also, these stents have the potential of allowing the vessel growth that does not require surgical removal. The vast application area will encourage patients to undergo stent implantation surgery.”

According to the report, there has been an increase in the incidence and prevalence of cardiac diseases, globally, with the sudden cardiac arrest being the leading cause of death among individuals aged above 40. The rise in vascular disorders has led to an increased sales of access devices in treating cardiac and peripheral disorders. According to CDC, every year, about 8.5 million people in the US aged above 60 suffer from PAD, which is a result of plaque formation in peripheral arteries (leg or pelvis). In the US, about 102,600 PCI procedures were performed in 2015, and these numbers have doubled over the last two years. In 2015, about 18.66 million vascular guide wires units were in demand with coronary guide wires accounting for 14.13 million units and peripheral guide wires with 4.53 million units.

Further, the report states that regulatory bodies have imposed a stringent labeling requirement, and regulatory framework for interventional cardiology devices, such as coronary stents, PTCA catheters, atherectomy devices, LAA closure or occlusion devices as their use leads to various complications. Medical devices are considered to have high risks involved and need to undergo safety examinations to demonstrate medical efficacy before being approved by regulatory agencies. Interventional cardiology devices are Class III devices and require extended clinical trials and PMA applications. Strict product approval processes and safety regulations make it difficult for manufacturers to launch new products in the market. In the US, interventional cardiology devices need to fulfill the US FDA regulations that govern all medical devices. The US FDA prevents unsafe and ineffective devices from entering or remaining in the market. Stringent US FDA regulations have delayed the approval of many products.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 6
  • Abbott Vascular
  • Boston Scientific
  • Cordis
  • Medtronic
  • St. Jude Medical
  • Aachen Resonance
  • Acrostak
  • Alvimedica
  • AngioScore
  • Arthesys
  • Asahi Intecc
  • AtriCure
  • B. Braun
  • Biosensors International
  • Biotronik
  • BrosMed Medical
  • C.R. Bard
  • Cardionovum
  • Coherex Medical
  • Cook Medical
  • Cardiovascular Systems
  • Elixir Medical
  • Fortimedix
  • Gadelius Medical
  • GaltNeedleTech
  • Gore Medical
  • Hexacath
  • JOTEC
  • Lepu Medical Technology
  • Medinol
  • Meril Life Sciences
  • Merit Medical Systems
  • MicroPort Scientific
  • Natec Medical
  • OptiMed
  • Reva Medical
  • SHOCKWAVE Medical
  • Simeks Medical
  • Smiths Medical
  • Spectranetics
  • STENTYS
  • Svelte medical
  • Teleflex
  • Terumo
  • Tokai Medical Products
  • US Endovascular
  • Volcano
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll